Relevant bibliographies by topics / Cardioncologia

Contents

  1. Journal articles
  2. Dissertations / Theses

Academic literature on the topic 'Cardioncologia'

Author: Grafiati
Published: 11 March 2023
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cardioncologia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cardioncologia"

1

Cardinale, Daniela Maria. "Ruolo dei biomarcatori cardiaci in cardioncologia nell’identificazione precoce della cardiotossicità." Cardiologia Ambulatoriale 2, no. 2 (2024): 167–82. http://dx.doi.org/10.17473/1971-6818-2024-2-7.

Full text
Abstract:
La cardiotossicità è un importante effetto collaterale delle terapie antitumorali che influisce sulla qualità della vita e sulla sopravvivenza complessiva dei pazienti oncologici. La diagnosi precoce è cruciale per l’applicazione di strategie terapeutiche preventive e di supporto. La misurazione dei biomarcatori cardiaci specifici può diventare un metodo di routine utile per identificare i pazienti più inclini a sviluppare cardiotossicità e nei quali una strategia farmacologica preventiva e un monitoraggio cardiaco più stretto sono fondamentali. Sia le troponine che i peptidi natriuretici hann
APA, Harvard, Vancouver, ISO, and other styles
2

Todaro, Maria Chiara, Lilia Oreto, Rubina Qamar, Timothy E. Paterick, Scipione Carerj, and Bijoy K. Khandheria. "Cardioncology: State of the heart." International Journal of Cardiology 168, no. 2 (2013): 680–87. http://dx.doi.org/10.1016/j.ijcard.2013.03.133.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Penna, Claudia. "Redox and Nitrosative Signaling and Stress." Antioxidants 9, no. 12 (2020): 1237. http://dx.doi.org/10.3390/antiox9121237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chatterjee, Shambhabi, Shashi Kumar Gupta, Christian Bär, and Thomas Thum. "Noncoding RNAs: potential regulators in cardioncology." American Journal of Physiology-Heart and Circulatory Physiology 316, no. 1 (2019): H160—H168. http://dx.doi.org/10.1152/ajpheart.00418.2018.

Full text
Abstract:
Cancer is the leading cause of morbidity and mortality in the United States and globally. Owing to improved early diagnosis and advances in oncological therapeutic options, the number of cancer survivors has steadily increased. Such efficient cancer therapies have also lead to alarming increase in cardiovascular complications in a significant proportion of cancer survivors, due to adverse cardiovascular effects such as cardiotoxicity, cardiac atrophy, and myocarditis. This has emerged as a notable concern in healthcare and given rise to the new field of cardioncology, which aims at understandi
APA, Harvard, Vancouver, ISO, and other styles
5

Cardinale, Daniela, Vincenzo Caruso, and Carlo M. Cipolla. "The breast cancer patient in the cardioncology unit." Journal of Thoracic Disease 10, S35 (2018): S4306—S4322. http://dx.doi.org/10.21037/jtd.2018.10.06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lestuzzi, C. "Cardioncology, oncocardiology. Are we barking up the wrong tree?" International Journal of Cardiology 167, no. 2 (2013): 307–9. http://dx.doi.org/10.1016/j.ijcard.2013.04.148.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Printz, Carrie. "International Cardioncology Society tackles heart problems in cancer patients." Cancer 117, no. 9 (2011): 1785–87. http://dx.doi.org/10.1002/cncr.26155.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Throndson, K., D. Grantham, and B. Laurila. "Nursing Collaboration to Improve Management of CardiOncology In-Patient Population." Canadian Journal of Cardiology 32, no. 10 (2016): S330. http://dx.doi.org/10.1016/j.cjca.2016.07.582.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Printz, Carrie. "Cardioncology pioneer sees promise in new drugs, case management approaches." Cancer 117, no. 9 (2011): 1787. http://dx.doi.org/10.1002/cncr.26157.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chazova, I. E., E. V. Oschepkova, M. Yu Kirillova, and G. Ch Sharipova. "Cardioncology: management of arterial hypertension in patients with cancer on chemotherapy." Systemic Hypertension 12, no. 2 (2015): 6–7. http://dx.doi.org/10.26442/sg29054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cardioncologia"

1

VALLERIO, Paola. "APPLICAZIONE DI LINEE GUIDA E PERCORSI ASSISTENZIALI IN CARDIO-ONCOLOGIA: PREMESSE ALLA CREAZIONE DI UN REGISTRO REGIONALE." Doctoral thesis, 2016. http://hdl.handle.net/11562/939618.

Full text
Abstract:
La cardio-oncologia, disciplina finalizzata alla diagnosi, alla prevenzione e/o al trattamento delle complicanze cardiovascolari (aritmie, disfunzioni contrattili, ischemia o disturbi pressori, ma anche di eventi emocoagulativi) delle terapie antitumorali, è in continua espansione in considerazione della disponibilità crescente dei trattamenti antitumorali e dell’aumento, anche in Italia, del numero di casi prevalenti (numero di persone vive dopo una diagnosi di tumore), pari a circa 3 milioni stimati per il 2015, con un incremento del 17% rispetto al 2010 (+20% per i maschi e +15% per le femm
APA, Harvard, Vancouver, ISO, and other styles
2

Fontes, Joana Baltazar. "Cardiotoxicity of cancer therapy: a cost-benefit analysis of a cardioncology assessment in Portugal." Master's thesis, 2019. http://hdl.handle.net/10071/19515.

Full text
Abstract:
Cardiotoxicity caused by cancer therapy can be monitored using LVEF assessment. This dissertation aims to develop a cost-benefit model to analyze a LVEF assessment using a healthcare payer perspective and five, ten and thirty years time horizon. A Markov model, informed by the retrospective clinical course of 109 patients followed by Hospital de Santa Maria, Portugal on transitional probabilities, was built to assess the cost-benefit of LVEF assessment. Costs and utilities were assessed over a 5, 10 and 30-year range, with sensitivity analyses for significant variables. In the reference cases
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cardioncologia' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography